The invention pertains to the field of adoptive cell immunotherapy. Itprovides with engineered immune cells comprisinggenetic alteration into genes which are involved into immune functionsdownregulation, especially in response to environment signalssuch as nutrients depletion. Such method allows the production of more potentimmune cells in the context of tumors' microenvironment.